More Aggressive On CVS

I am taking a slightly more aggressive stance on CVS, after lowering my exposure last week when the stock spiked above 38. I believe that the Express Script's premium bid for Medco shows that the PBM part of CVS's business deserves to trade at a premium.

No comments: